Financing Technologys Frontier: Decision–Making Models for Investors and Advisors

Praise for Financing Technology’s Frontier
Second Edition
"Today, developments in biotechnology are converging with demographics, third world markets, the maturation of care management and consumer empowerment to assure us a totally transformed health care and life sciences industry in the next five years.
Financial advisors with worldwide knowledge sharing and tightly linked practice networks to meet demands–– not only in the U.S., Europe, Australia, and Japan, but in changing markets in China, Latin America, and Africa–– will be the preferred advisors of the future.
Rich Shanley, Partner in our tri–state healthcare and life sciences practice, is such an advisor and with this book, takes the reader through the real world of financing companies at the cutting edge of technological innovation. Financing Technology’s Frontier is an important reference for anyone interested in the future of the rapidly evolving technology."
–– Robert Go
Global Leader, Life Sciences, Deloitte Touche Tohmatsu
"Financing Technology’s Frontier is an excellent guide for investors who are seeking to be on the ground level of cutting edge and often overlooked investment opportunities, such as New York City’s burgeoning biotech industry."
–– Maria Gotsch
Senior Vice President, New York City Investment Fund
"There’s more than one way to raise money for biotech businesses, and Richard Shanley understands that. In this new edition of Financing Technology′s Frontier, he takes a serious look at what bioparks and academic medical centers are doing to encourage the innovations and breakthroughs that will constitute the cutting edge of the life sciences arena for years to come."
–– Dr. William Polf
Senior Vice President, New York–Presbyterian Hospital

Spis treści:
Foreword.
Preface.
Acknowledgments.
About the Au thor.
Chapter 1. Sharing the Excitement of Discovery.
Chapter 2. Growth Models that Encourage Investment.
Chapter 3. Where to Find Capital—Part I: Venture Capital.
Chapter 4. Where to Find Capital—Part II: Public Markets and Private Placements.
Chapter 5. Creative and Alternative Financing Strategies.
Chapter 6. Strategic Alliances and Corporate Partnerships.
Chapter 7. Mergers and Acquisitions.
Chapter 8. Profiles of Corporate Partnerships.
Chapter 9. Tax Planning Strategies.
Chapter 10. How to Attract and Retain Quality Employees and Management Teams.
Chapter 11. Corporate Governance in a Post–Enron World.
Chapter 12. Biotechnology Beyond the U.S. Borders.
Chapter 13. Technology’s Future—The View from the Frontier.
Afterword.
Index.


Nota biograficzna:
Richard P. Shanley is a Partner in Deloitte Touche Tohmatsu serving in the northeast region of their healthcare and life sciences industry practice. He has over twenty–seven years of diversified professional services experience, encompassing audits and public stock offerings for biotech, pharmaceutical, and high–tech companies. He has founded and led industry practice groups in both health sciences and new media, and is a recognized authority on financing for emerging growth companies.

Okładka tylna:
Praise for Financing Technology’s Frontier
Second Edition
"Today, developments in biotechnology are converging with demographics, third world markets, the maturation of care management and consumer empowerment to assure us a totally transformed health care and life sciences industry in the next five years.
Financial advisors with worldwide knowledge sharing and tightly linked practice networks to meet demands–– not only in the U.S., Europe, Australia, and Japan, but in changing markets in China, Latin America, and Africa–– will be the preferred ad visors of the future.
Rich Shanley, Partner in our tri–state healthcare and life sciences practice, is such an advisor and with this book, takes the reader through the real world of financing companies at the cutting edge of technological innovation. Financing Technology’s Frontier is an important reference for anyone interested in the future of the rapidly evolving technology."
–– Robert Go
Global Leader, Life Sciences, Deloitte Touche Tohmatsu
"Financing Technology’s Frontier is an excellent guide for investors who are seeking to be on the ground level of cutting edge and often overlooked investment opportunities, such as New York City’s burgeoning biotech industry."
–– Maria Gotsch
Senior Vice President, New York City Investment Fund
"There’s more than one way to raise money for biotech businesses, and Richard Shanley understands that. In this new edition of Financing Technology′s Frontier, he takes a serious look at what bioparks and academic medical centers are doing to encourage the innovations and breakthroughs that will constitute the cutting edge of the life sciences arena for years to come."
–– Dr. William Polf
Senior Vice President, New York–Presbyterian Hospital